Istradefylline 40 mg

DRUG3 trials

Sponsors

Kyowa Kirin Co., Ltd., Medical University of South Carolina

Conditions

ApathyIdiopathic Parkinson's DiseaseParkinson DiseaseParkinson's Disease

Phase 1

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

CompletedNCT02174250

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2014-06-30End: 2014-12-31Updated: 2024-04-25

Phase 3

A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

CompletedNCT01968031

Kyowa Kirin Co., Ltd.Idiopathic Parkinson's Disease

Start: 2013-10-31End: 2016-10-31Updated: 2024-04-25

Unknown Phase

Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.

TerminatedNCT05182151

Medical University of South CarolinaApathy, Parkinson Disease

Start: 2022-07-29End: 2023-12-01Updated: 2026-02-02